Cargando…

Activated Hepatic Stellate Cells in Hepatocellular Carcinoma: Their Role as a Potential Target for Future Therapies

Hepatocellular carcinoma (HCC) is a global healthcare challenge, which affects more than 815,000 new cases every year. Activated hepatic stellate cells (aHSCs) remain the principal cells that drive HCC onset and growth. aHSCs suppress the anti-tumor immune response through interaction with different...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ali, Esraa, Trailin, Andriy, Ambrozkiewicz, Filip, Liška, Václav, Hemminki, Kari
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9741299/ https://www.ncbi.nlm.nih.gov/pubmed/36499616 http://dx.doi.org/10.3390/ijms232315292

Ejemplares similares

Long Non-Coding RNA and microRNA Interplay in Colorectal Cancer and Their Effect on the Tumor Microenvironment
por: Rajtmajerová, Marie, et al.
Publicado: (2022)

T- and B-Cells in the Inner Invasive Margin of Hepatocellular Carcinoma after Resection Associate with Favorable Prognosis
por: Trailin, Andriy, et al.
Publicado: (2022)

Theranostics Nanomedicine Applications for Colorectal Cancer and Metastasis: Recent Advances
por: Kasi, Phanindra Babu, et al.
Publicado: (2023)

CTNNB1 mutations, TERT polymorphism and CD8+ cell densities in resected hepatocellular carcinoma are associated with longer time to recurrence
por: Ambrozkiewicz, Filip, et al.
Publicado: (2022)

Survival in Colon, Rectal and Small Intestinal Cancers in the Nordic Countries through a Half Century
por: Tichanek, Filip, et al.
Publicado: (2023)

Long-term survival trends for primary liver and pancreatic cancers in the Nordic countries
por: Hemminki, Kari, et al.
Publicado: (2022)

Cancer Stem Cell and Hepatic Stellate Cells in Hepatocellular Carcinoma
por: Quiroz Reyes, Adriana G., et al.
Publicado: (2023)

Hepatic Stellate Cell Modulates the Immune Microenvironment in the Progression of Hepatocellular Carcinoma
por: Wang, Pei-Wen, et al.
Publicado: (2022)

Pancreatic stellate cells in pancreatic cancer: as potential targets for future therapy
por: Wang, Zhengfeng, et al.
Publicado: (2023)

The role of hepatic stellate cells in the regulation of T-cell function and the promotion of hepatocellular carcinoma
por: ZHAO, WENXIU, et al.
Publicado: (2012)

Serotonin Activated Hepatic Stellate Cells Contribute to Sex Disparity in Hepatocellular Carcinoma
por: Yang, Qiqi, et al.
Publicado: (2017)

Crosstalk between hepatic stellate cells and tumor cells in the development of hepatocellular carcinoma
por: Ma, Ya-Nan, et al.
Publicado: (2021)

Inhibition of Hepatic Stellate Cell Activation Suppresses Tumorigenicity of Hepatocellular Carcinoma in Mice
por: Kang, Min-Jung, et al.
Publicado: (2021)

Dexmedetomidine promotes the progression of hepatocellular carcinoma through hepatic stellate cell activation
por: Chen, Peng, et al.
Publicado: (2020)

Familial Risks for Liver, Gallbladder and Bile Duct Cancers and for Their Risk Factors in Sweden, a Low-Incidence Country
por: Hemminki, Kari, et al.
Publicado: (2022)

Population-Attributable Fractions of Personal Comorbidities for Liver, Gallbladder, and Bile Duct Cancers
por: Hemminki, Kari, et al.
Publicado: (2023)

Intratumoral Hepatic Stellate Cells as a Poor Prognostic Marker and a New Treatment Target for Hepatocellular Carcinoma
por: Sun, Bin, et al.
Publicado: (2013)

Survival in melanoma in the nordic countries into the era of targeted and immunological therapies
por: Tichanek, Filip, et al.
Publicado: (2023)

Activated hepatic stellate cells promote angiogenesis via interleukin-8 in hepatocellular carcinoma
por: Zhu, Bing, et al.
Publicado: (2015)

Hepatic Stellate Cells Secreted Hepatocyte Growth Factor Contributes to the Chemoresistance of Hepatocellular Carcinoma
por: Yu, Guofeng, et al.
Publicado: (2013)

Hepatic stellate cells limit hepatocellular carcinoma progression through the orphan receptor endosialin
por: Mogler, Carolin, et al.
Publicado: (2017)

Second Primary Cancers After Liver, Gallbladder and Bile Duct Cancers, and These Cancers as Second Primary Cancers
por: Zheng, Guoqiao, et al.
Publicado: (2021)

Potential drug mechanism(s) targeting the contractile status of hepatic stellate cells
por: Bucolo, Claudio, et al.
Publicado: (2012)

Targeted Therapy of Hepatitis B Virus-Related Hepatocellular Carcinoma: Present and Future
por: Koh, Sarene, et al.
Publicado: (2016)

Clinical significance and gene expression study of human hepatic stellate cells in HBV related-hepatocellular carcinoma
por: Liao, Rui, et al.
Publicado: (2013)

CCN1/Cyr61 enhances the function of hepatic stellate cells in promoting the progression of hepatocellular carcinoma
por: Li, Zhi-Qiang, et al.
Publicado: (2018)

Stimulated hepatic stellate cell promotes progression of hepatocellular carcinoma due to protein kinase R activation
por: Imai, Yusuke, et al.
Publicado: (2019)

Fibroblast Growth Factor 9 is expressed by activated hepatic stellate cells and promotes progression of hepatocellular carcinoma
por: Seitz, Tatjana, et al.
Publicado: (2020)

HK1 from hepatic stellate cell–derived extracellular vesicles promotes progression of hepatocellular carcinoma
por: Chen, Qi-tao, et al.
Publicado: (2022)

Nuclear GAPDH is vital for hypoxia-induced hepatic stellate cell apoptosis and is indicative of aggressive hepatocellular carcinoma behavior
por: Gong, Yihang, et al.
Publicado: (2019)

Activated Hepatic Stellate Cells (HSCs) Exert Immunosuppressive Effects in Hepatocellular Carcinoma by Producing Complement C3
por: Xu, Yaping, et al.
Publicado: (2020)

Hepatitis B Virus Promotes Hepatocellular Carcinoma Progression Synergistically With Hepatic Stellate Cells via Facilitating the Expression and Secretion of ENPP2
por: Deng, Wanyu, et al.
Publicado: (2021)

Hepatocellular Carcinoma: Past and Future of Molecular Target Therapy
por: Nguyen, Khanh, et al.
Publicado: (2015)

The potential of mecciRNA in hepatic stellate cell to regulate progression of nonalcoholic hepatitis
por: Liu, Boqiang, et al.
Publicado: (2022)

Rat hepatic stellate cells alter the gene expression profile and promote the growth, migration and invasion of hepatocellular carcinoma cells
por: WANG, ZHI-MING, et al.
Publicado: (2014)

Activated hepatic stellate cells play pivotal roles in hepatocellular carcinoma cell chemoresistance and migration in multicellular tumor spheroids
por: Song, Yeonhwa, et al.
Publicado: (2016)

Activated hepatic stellate cells promote epithelial-to-mesenchymal transition in hepatocellular carcinoma through transglutaminase 2-induced pseudohypoxia
por: Ma, Hui, et al.
Publicado: (2018)

Remodeling of hepatic stellate cells orchestrated the stroma-derived oxaliplatin-resistance through CCN3 paracrine in hepatocellular carcinoma
por: Liao, Xia, et al.
Publicado: (2019)

STMN1 upregulation mediates hepatocellular carcinoma and hepatic stellate cell crosstalk to aggravate cancer by triggering the MET pathway
por: Zhang, Rui, et al.
Publicado: (2019)

Secretome of senescent hepatic stellate cells favors malignant transformation from nonalcoholic steatohepatitis-fibrotic progression to hepatocellular carcinoma
por: Zhou, Yuan, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_0bve471i9t4orohrvn6b3261t6